This inventor holds 1 USPTO granted patent. Top assignee: Cha University Industry-Academic Cooperation Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Su Yeon Lee: Innovator in Ovarian Reactivity Diagnostics
Introduction: Su Yeon Lee is a notable inventor based in Pocheon-si, South Korea. She has made significant contributions to the field of reproductive health through her innovative research and patenting efforts. Her work focuses on developing diagnostic tools that enhance our understanding of ovarian function.
Latest Patents: Su Yeon Lee holds a patent for a biomarker that aids in diagnosing or predicting the reactivity of the ovary to follicle-stimulating hormone (FSH). This patent, titled "Biomarker for diagnosing or predicting reactivity of ovary to FSH and use thereof," provides a composition or kit that utilizes miRNA present in blood, follicular fluid, granulosa cells, and cumulus cells. This innovative approach allows for easy diagnosis and prediction of symptoms or diseases related to abnormal ovarian reactivity to FSH. She has 1 patent to her name.
Career Highlights: Su Yeon Lee is affiliated with the Cha University Industry-Academic Cooperation Foundation, where she continues her research and development efforts. Her work is instrumental in bridging the gap between academic research and practical applications in the medical field.
Collaborations: Among her colleagues are Kyung Ah Lee and Mi Kyoung Koong, who contribute to her research endeavors. Their collaborative efforts enhance the quality and impact of their work in the field of reproductive health.
Conclusion: Su Yeon Lee's innovative contributions to ovarian reactivity diagnostics exemplify the importance of research in advancing medical science. Her work not only aids in understanding ovarian function but also has the potential to improve patient outcomes in reproductive health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile